MFIC Stock Analysis: MidCap Financial Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 834m USD | 12M Return: -11.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.70M
EPS Trend: -81.8%
Qual. Beats: 0
Rev. Trend: 63.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
MidCap Financial Investment Corporation (NASDAQ: MFIC), formerly known as Apollo Investment Corporation, is a Business Development Company (BDC) operating as a closed-end, externally managed, non-diversified investment vehicle under the Investment Company Act of 1940. The firm specializes in private debt and equity investments, primarily targeting leveraged buyouts, acquisitions, recapitalizations, growth capital, and refinancing transactions involving middle-market companies. Its investment offerings span a wide range of structures, including mezzanine debt, first and second lien secured loans, unitranche loans, senior secured and unsecured debt, subordinated loans, preferred and common equity, warrants, and PIPE transactions. The fund may also allocate capital to CLOs, credit-linked notes, high-yield bonds, distressed debt, and certain public-company securities.
As a BDC, the company is structured to provide financing to small and mid-sized private businesses, an industry segment that plays a notable role in supplying capital to firms that may lack access to traditional bank financing. BDCs are generally required to distribute the majority of their taxable income to shareholders in order to maintain their pass-through tax treatment, which typically results in income-oriented returns for investors. The firm pursues opportunities across a broad range of industries, including business services, healthcare and pharmaceuticals, energy, manufacturing, retail, financial services, telecommunications, media, aerospace and defense, consumer products, and chemicals, among others.
- Net interest margin compresses as base rates decline
- Middle market credit losses rise on weaker portfolio quality
- Loan origination growth expands net investment income
| Net Income: 5.97m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 13.33 > 1.0 |
| NWC/Revenue: -21.06% < 20% (prev 56.26%; Δ -77.33% < -1%) |
| CFO/TA 0.04 > 3% & CFO 133.8m > Net Income 5.97m |
| Net Debt (1.83b) to EBITDA (102.1m): 17.90 < 3 |
| Current Ratio: 0.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (89.6m) vs 12m ago -4.38% < -2% |
| Gross Margin: 90.98% > 18% (prev 48.55%; Δ 42.43% > 0.5%) |
| Asset Turnover: 7.62% > 50% (prev 6.96%; Δ 0.66% > 0%) |
| Interest Coverage Ratio: 0.81 > 6 (EBIT TTM 102.1m / Interest Expense TTM 126.6m) |
| A: -0.02 (Total Current Assets 73.4m - Total Current Liabilities 125.0m) / Total Assets 3.07b |
| B: -0.46 (Retained Earnings -1.40b / Total Assets 3.07b) |
| C: 0.03 (EBIT TTM 102.1m / Avg Total Assets 3.21b) |
| D: 0.62 (Book Value of Equity 1.18b / Total Liabilities 1.89b) |
| Altman-Z'' = -0.73 = B |
As of July 08, 2026, the stock is trading at USD 9.98 with a total of 512,191 shares traded. Over the past week, the price has changed by -0.80%, over one month by -2.35%, over three months by -10.90% and over the past year by -11.16%.
Current recommended Stop Loss: 9.60 (which is 3.8% or 1.5 ATR below the current price).
MidCap Financial Investment has received a consensus analysts rating of 3.89. Therefore, it is recommended to buy MFIC.
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 11.4 | 14% |
P/E Trailing = 168.6667
P/E Forward = 8.0257
P/S = 2.6548
P/B = 0.7052
P/EG = 3.1217
Revenue TTM = 245.0m USD
EBIT TTM = 102.1m USD
EBITDA TTM = 102.1m USD
Long Term Debt = 1.75b USD (estimated: total debt 1.87b - short term 125.0m)
Short Term Debt = 125.0m USD (from shortTermDebt, last quarter)
Debt = 1.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.83b USD (calculated: Debt 1.87b - CCE 42.6m)
Enterprise Value = 2.66b USD (833.6m + Debt 1.87b - CCE 42.6m)
Interest Coverage Ratio = 0.81 (Ebit TTM 102.1m / Interest Expense TTM 126.6m)
EV/FCF = 9.79x (Enterprise Value 2.66b / FCF TTM 271.8m)
FCF Yield = 10.21% (FCF TTM 271.8m / Enterprise Value 2.66b)
FCF Margin = 111.0% (FCF TTM 271.8m / Revenue TTM 245.0m)
Net Margin = 2.44% (Net Income TTM 5.97m / Revenue TTM 245.0m)
Gross Margin = 90.98% ((Revenue TTM 245.0m - Cost of Revenue TTM 22.1m) / Revenue TTM)
Gross Margin QoQ = 88.92% (prev none%)
Tobins Q-Ratio = 0.87 (Enterprise Value 2.66b / Total Assets 3.07b)
Interest Expense / Debt = 6.77% (Interest Expense 126.6m / Debt 1.87b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 80.6m (EBIT 102.1m * (1 - 21.00%))
Current Ratio = 0.59 (Total Current Assets 73.4m / Total Current Liabilities 125.0m)
Debt / Equity = 1.59 (Debt 1.87b / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = 17.90 (Net Debt 1.83b / EBITDA 102.1m)
Debt / FCF = 6.72 (Net Debt 1.83b / FCF TTM 271.8m)
Total Stockholder Equity = 1.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.19% (Net Income 5.97m / Total Assets 3.07b)
RoE = 0.46% (Net Income TTM 5.97m / Total Stockholder Equity 1.31b)
RoCE = 3.34% (EBIT 102.1m / Capital Employed (Equity 1.31b + L.T.Debt 1.75b))
RoIC = 2.64% (NOPAT 80.6m / Invested Capital 3.06b)
WACC = 6.36% (E(833.6m)/V(2.70b) * Re(8.64%) + D(1.87b)/V(2.70b) * Rd(6.77%) * (1-Tc(0.21)))
Discount Rate = 8.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 39.58 | Cagr: 15.09%
[DCF] Terminal Value 75.44% ; FCFF base≈271.8m ; Y1≈272.9m ; Y5≈289.1m
[DCF] Fair Price = 32.40 (EV 4.50b - Net Debt 1.83b = Equity 2.67b / Shares 82.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -81.78 | EPS CAGR: -6.14% | SUE: 0.70 | # QB: 0
Revenue Correlation: 63.61 | Revenue CAGR: 2.39% | SUE: -0.50 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.37 | Chg30d=+10.14% | Revisions=+29% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.34 | Chg30d=+0.21% | Revisions=-12% | Analysts=6
EPS current Year (2026-12-31): EPS=1.41 | Chg30d=+3.88% | Revisions=+44% | GrowthEPS=-7.2% | GrowthRev=-16.4%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=-3.46% | Revisions=-67% | GrowthEPS=-10.9% | GrowthRev=-6.5%
[Analyst] Revisions Ratio: -4% (up=10, down=11)